Taurine in health and diseases: Consistent evidence from experimental and epidemiological studies

Journal of Biomedical Science

Volumn 17, Issue SUPPL. 1, 2010, Pages

  Yamori, Yukio ^a   Taguchi, Takashi ^a   Hamada, Atsumi ^a   Kunimasa, Kazuhiro ^a   Mori, Hideki ^a   Mori, Mari ^a  

^a MUKOGAWA WOMEN'S UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; MAGNESIUM; SODIUM; TAURINE;

ATHEROSCLEROSIS; BLOOD VESSEL WALL; BODY MASS; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CONFERENCE PAPER; DIASTOLIC BLOOD PRESSURE; FATTY LIVER; FRUIT; HEART RATE; HIGH RISK POPULATION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; LIPID STORAGE; LIVER; LONGEVITY; MILK; MORTALITY; NONHUMAN; NUT; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SEA FOOD; STROKE; SYSTOLIC BLOOD PRESSURE; VEGETABLE; ANIMAL; BLOOD PRESSURE; CHOLESTEROL INTAKE; DIET; FAT INTAKE; METABOLISM; PATHOLOGY; PHYSIOLOGY; REVIEW; RISK; RISK FACTOR;

RATTUS;

ANIMALS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CHOLESTEROL, DIETARY; DIET; DIETARY FATS; HUMANS; HYPERTENSION; LIVER; MAGNESIUM; RISK; RISK FACTORS; STROKE; TAURINE;

EID: 77956027828     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-17-S1-S6     Document Type: Conference Paper

References (62)

1. Development of a strain of spontaneously hypertensive rats. K Okamoto K Aoki, Jpn Circ J 1963 27 282 293 13939773
2. Development of the spontaneously hypertensive rat (SHR) and of various spontaneous rat models, and their implications. Y Yamori, Handbook of Hypertension Elsevier, de Jong W. Amsterdam, 1984 224 239
3. Establishment of the stroke-prone spontaneously hypertensive rat (SHR). T Okamoto Y Yamori A Nagaoka, Circ Res 1974 34/35 143 153
4. The stroke-prone spontaneously hypertensive rat: Contribution to risk factor analysis and prevention of hypertensive diseases. Y Yamori, Handbook of Hypertension Elsevier, de Jong W. Amsterdam, 1984 240 255
5. CARDIAC (Cardiovascular Diseases and Alimentary Comparison) study protocol. WHO and WHO Collaborating Centers, Shimane/Geneva 1986
6. Hypertension and biological dietary markers in urine and blood: A progress report from the CARDIAC study group. Y Yamori, New Horizons in Preventing Cardiovascular Diseases Elsevier, Yamori Y, Strasser T. Amsterdam, 1989 111 126
7. Gene-environment interaction in hypertension, stroke and atherosclerosis in experimental models and supportive findings from a world-wide cross-sectional epidemiological survey: a WHO-CARDIAC study. Y Yamori Y Nara S Mizushima S Murakami K Ikeda M Sawamura T Nabika R Horie, Clin Exp Pharmacol Physiol Suppl 1992 20 43 52 1446409
8. Male cardiovascular mortality and dietary markers in 25 population samples of 16 countries. Y Yamori L Liu S Mizushima K Ikeda Y Nara, J Hypertens 2006 24 1499 1505 10.1097/01.hjh.0000239284.12691.2e 16877951
9. Effect of dietary taurine on blood pressure in spontaneously hypertensive rats. Y Nara Y Yamori W Lovenberg, Biochem Pharmacol 1978 27 2689 2692 10.1016/0006-2952(78)90043-6 728224
10. Is taurine a preventive nutritional factor of cardiovascular diseases or just a biological marker of nutrition? Y Yamori Y Nara K Ikeda S Mizushima, Adv Exp Med Biol 1996 403 623 629 8915403
11. Distribution of twenty-four hour urinary taurine excretion and association with ischemic heart disease mortality in 24 populations of 16 countries: results from the WHO-CARDIAC study. Y Yamori L Liu K Ikeda A Miura S Mizushima T Miki Y Nara, Hypertens Res 2001 24 453 457 10.1291/hypres.24.453 11510759
12. Taurine as the nutritional factor for the longevity of the Japanese revealed by a world-wide epidemiological survey. Y Yamori L Liu M Mori M Sagara S Murakami Y Nara S Mizushima, Adv Exp Med Biol 2009 643 13 25 full-text 19239132
13. The restorative effect of taurine on experimental nonalcoholic steatohepatitis. SW Chen YX Chen J Shi Y Lin WF Xie, Dig Dis Sci 2006 51 2225 2234 10.1007/s10620-006-9359-y 17080243
14. Low cardiovascular risks in the middle aged males and females excreting greater 24-hour urinary taurine and magnesium in 41 WHO-CARDIAC study populations in the world. Y Yamori T Taguchi M Mori H Mori, J Biomed Sci. Citation from within the same Supplement.
15. Predictive and preventive pathology of cardiovascular diseases. Y Yamori, Acta Pathol Jpn 1989 39 683 705 2694754
16. Pathogenesis and dietary prevention of cerebrovascular diseases in animal models and epidemiological evidence for the applicability in man. Y Yamori R Horie Y Nara M Tagami M Kihara M Mano H Ishio, Prevention of Cardiovascular Diseases, an Approach to Active Long Life Elsevier, Yamori Y, Lenfant C. Amsterdam, 1987 163 177
17. Immunocytochemical study of cerebral perforating arteries in patients with cerebral infactions. M Tagami T Tsukada A Kubota A Nara Y Yamori, Acta Histochem Cytochem 1993 26 109 115
18. Taurine and its chloramine: modulators of immunity. GB Schuller Levis E Park, Neurochem Res 2004 29 117 126 10.1023/B:NERE.0000010440.37629.17 14992270
19. Taurine chloramine activates Nrf2, increases HO-1 expression and protects cells from death caused by hydrogen peroxide. J Sun Jang S Piao YN Cha C Kim, J Clin Biochem Nutr 2009 45 37 43 10.3164/jcbn.08-262 19590705
20. Theodore Cooper Memorial Lecture. Hypertension and the pathogenesis of atherosclerosis. Oxidative stress and the mediation of arterial inflammatory response: a new perspective. RW Alexander, Hypertension 1995 25 155 161 7843763
21. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. PM Ridker N Rifai L Rose JE Buring NR Cook, N Engl J Med 2002 347 1557 1565 10.1056/NEJMoa021993 12432042
22. Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident ischemic stroke in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study. CM Ballantyne RC Hoogeveen H Bang J Coresh AR Folsom LE Chambless M Myerson KK Wu AR Sharrett E Boerwinkle, Arch Intern Med 2005 165 2479 2484 10.1001/archinte.165.21.2479 16314544
23. Dietary cod protein reduces plasma C-reactive protein in insulin-resistant men and women. V Ouellet SJ Weisnagel J Marois J Bergeron P Julien R Gougeon A Tchernof BJ Holub H Jacques, J Nutr 2008 138 2386 2391 10.3945/jn.108.092346 19022962
24. Pathogenesis of acute arterial fat deposition in spontaneously hypertensive rats. Y Yamori Y Hamashima R Horie H Handa M Sato, Jpn Circ J 1975 39 601 609 1152192
25. Hypertension as an important factor for cerebrovascular atherogenesis in rats. Y Yamori R Horie M Sato M Fukase, Stroke 1976 7 120 125 1265803
26. Hypolipidemic effect of taurine in stroke-prone spontaneously hypertensive rats. S Murakami I Yamagishi Y Asami Y Ohta Y Toda Y Nara Y Yamori, Pharmacology 1996 52 303 313 10.1159/000139395 8807674
27. Taurine accelerates the regression of hypercholesterolemia in stroke-prone spontaneously hypertensive rats. S Murakami Y Nara Y Yamori, Life Sci 1996 58 1643 1651 10.1016/0024-3205(96)00139-7 8632701
28. Effects of oral taurine supplementation on lipids and sympathetic nerve tone. S Mizushima Y Nara M Sawamura Y Yamori, Adv Exp Med Biol 1996 403 615 622 8915402
29. Dietary taurine enhances cholesterol degradation and reduces serum and liver cholesterol concentrations in rats fed a high-cholesterol diet. H Yokogoshi H Mochizuki K Nanami Y Hida F Miyachi H Oda, J Nutr 1999 129 1705 1712 10460208
30. Effect of taurine on cholesterol metabolism in hamsters: up-regulation of low density lipoprotein (LDL) receptor by taurine. S Murakami Y Kondo Y Toda H Kitajima K Kameo M Sakono N Fukuda, Life Sci 2002 70 2355 2366 10.1016/S0024-3205(02)01507-2 12150200
31. Activated acyl coenzyme A-cholesterol acyltransferase as a possible cause of rapid arterial fat deposition in genetic hypertensive rat models for atherosclerosis. Y Yamori S Murakami Y Nara, J Vasc Med Biol 1991 3 268 270
32. LOX-1 mediates vascular lipid retention under hypertensive state. A Nakano N Inoue Y Sato N Nishimichi K Takikawa Y Fujita A Kakino K Otsui S Yamaguchi H Matsuda T Sawamura, J Hypertens 2000 10694180
33. The protective effects of taurine against renal damage by salt loading in Dahl salt-sensitive rats. Y Chiba K Ando T Fujita, J Hypertens 2002 20 2269 2274 10.1097/00004872-200211000-00027 12409966
34. Taurine rescues vascular endothelial dysfunction in streptozocin-induced diabetic rats: correlated with downregulation of LOX-1 and ICAM-1 expression on aortas. LJ Wang YH Yu LG Zhang Y Wang N Niu Q Li LM Guo, Eur J Pharmacol 2008 597 75 80 10.1016/j.ejphar.2008.08.031 18796303
35. High fat diet-induced liver injury and lipid metabolic disorder in arteriolipidosis-prone rat (ALR) [abstract]. K Kitamori M Kobayashi S Tsuchikura J Hiraoka-Yamamoto N Yasui Y Nara K Ikeda Y Yamori T Nakajima, Proceedings of the 2nd International Symposium on Lifestyle Related Diseases 2006 33
36. Stroke-prone SHR and arteriolipidosis-prone SHR as models for atherosclerosis: their mechanisms and application for nutritional and pharmacological studies. Y Yamori S Murakami Y Nara K Ikeda, Clin Exp Pharmacol Physiol Suppl 1995 22 244 245 10.1111/j.1440-1681.1995.tb02901.x 9072375
37. Food factors for atherosclerosis prevention: Asian perspective derived from analyses of worldwide dietary biomarkers. Y Yamori, Exp Clin Cardiol 2006 11 94 98 18651042
38. Food culture: Development and Education. Y Yamori, Paris: UNESCO 2009
39. Different associations of blood pressure with 24-hour urinary sodium excretion among pre- and post-menopausal women. WHO Cardiovascular Diseases and Alimentary Comparison (WHO-CARDIAC) Study. Y Yamori L Liu K Ikeda S Mizushima Y Nara FO Simpson, J Hypertens 2001 19 535 538 10.1097/00004872-200103001-00003 11327626
40. Resting heart rate in relation to blood pressure: Results from the World Health Organization-Cardiovascular Disease and Alimentary Comparison Study. L Liu S Mizushima K Ikeda Y Nara Y Yamori, Int J Cardiol 2000 10841964
41. Heart rate and the cardiovascular risk. P Palatini S Julius, J Hypertens 1997 15 3 17 10.1097/00004872-199715010-00001 9050965
42. Resting heart rate and cause-specific death in a 16.5-year cohort study of the Japanese general population. T Okamura T Hayakawa T Kadowaki Y Kita A Okayama P Elliott H Ueshima, Am Heart J 2004 147 1024 1032 10.1016/j.ahj.2003. 12.020 15199351
43. Hypotensive action of taurine in DOCA-salt rats - involvement of sympathoadrenal inhibition and endogenous opiate. Y Sato E Ogata T Fujita, Jpn Circ J 1991 55 500 508 2062001
44. Enhanced urinary epinephrine excretion by cold exposure: A possible predictor of hypertension in rat models and humans. M Mano Y Nara M Kihara R Horie J Endo Y Yamori, J Cardiovasc Pharmacol 1987 10 165 S166 10.1097/00005344-198710001-00030 2442511
45. Australian Aboriginals with highest risks and a new attempt for their nutritional improvement. M Mori Thorpe on behalf of Japan-Australian CARDIAC Group, Food Culture: Development and Education Paris: UNESCO, Yamori Y., 2009 97 101
46. Marked improvement in carbohydrate and lipid metabolism in diabetic Australian aborigines after temporary reversion to traditional lifestyle. K O'Dea, Diabetes 1984 33 596 603 10.2337/diabetes.33.6.596 6373464
47. Physiological actions of taurine. RJ Huxtable, Physiol Rev 1992 72 101 163 1731369
48. Expanding the circle 1975-1999: sulfur biochemistry and insights on the biological functions of taurine. RJ Huxtable, Adv Exp Med Biol 2000 483 1 25 full-text 11787586
49. MAPK activation and apoptotic alterations in hearts subjected to calcium paradox are attenuated by taurine. YJ Xu HK Saini M Zhang V Elimban NS Dhalla, Cardiovasc Res 2006 72 163 174 10.1016/j.cardiores.2006.06.028 16901476
50. Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. U Ozcan E Yilmaz L Ozcan M Furuhashi E Vaillancourt RO Smith CZ Görgün GS Hotamisligil, Science 2006 313 1137 1140 10.1126/science.1128294 16931765
51. High dietary taurine reduces apoptosis and atherosclerosis in the left main coronary artery: association with reduced CCAAT/enhancer binding protein homologous protein and total plasma homocysteine but not lipidemia. A Zulli E Lau BP Wijaya X Jin K Sutarga GD Schwartz J Learmont PJ Wookey A Zinellu C Carru DL Hare, Hypertension 2009 53 1017 1022 10.1161/HYPERTENSIONAHA.109.129924 19398656
52. Endothelial progenitor cell senescence is accelerated in both experimental hypertensive rats and patients with essential hypertension. T Imanishi C Moriwaki T Hano I Nishio, J Hypertens 2005 23 1831 1837 10.1097/01.hjh.0000183524.73746.1b 16148606
53. Taurine improves vascular tone through the suppression of peripheral sympathetic tone in endothelial progenitor cell senescence in hypertension [abstract]. T Hano H Kasano N Tomari T Kuriyama T Kawabe, Physiol Res 2008 57 44 45
54. Effect of taurine and estrogen on endothelial progenitor cell senescence in spontaneously hypertensive rats (SHR/Izm). T Hano T Kawabe, Clin Exp Hypertens 2000
55. Taurine and vitamin C modify monocyte and endothelial dysfunction in young smokers. FM Fennessy DS Moneley JH Wang CJ Kelly DJ Bouchier Hayes, Circulation 2003 107 410 415 10.1161/01.CIR.0000046447.72402.47 12551864
56. A review of the link between dietary magnesium and cardiovascular risk. Y Yamori S Mizushima, J Cardiovasc Risk 2000 7 31 35 10785871
57. Role of magnesium in the pathogenesis of hypertension. RM Touyz, Mol Aspects Med 2003 24 107 136 10.1016/S0098-2997(02)00094-8 12537992
58. Magnesium metabolism in hypertension and type 2 diabetes mellitus. M Barbagallo LJ Dominguez LM Resnick, Am J Ther 2007 14 375 385 10.1097/01.mjt.0000209676.91582.46 17667214
59. Intralymphocytic free calcium and magnesium in stroke-prone spontaneously hypertensive rats and effects of blood pressure and various antihypertensive agents. M Adachi Y Nara M Mano K Ikeda R Horie Y Yamori, Clin Exp Pharmacol Physiol 1993 20 587 593 10.1111/j.1440-1681.1993.tb01745.x 8222339
60. Effect of dietary magnesium supplementation on intralymphocytic free calcium and magnesium in stroke-prone spontaneously hypertensive rats. M Adachi Y Nara M Mano Y Yamori, Clin Exp Hypertens 1994 16 317 326 10.3109/ 10641969409072219 8038757
61. Oral magnesium supplementation reduces ambulatory blood pressure in patients with mild hypertension. LS Hatzistavri PA Sarafidis PI Georgianos IM Tziolas CP Aroditis PE Zebekakis MI Pikilidou AN Lasaridis, Am J Hypertens 2009 22 1070 1075 10.1038/ajh.2009.126 19617879
62. Magnesium inhibits norepinephrine release by blocking N-type calcium channels at peripheral sympathetic nerve endings. T Shimosawa K Takano K Ando T Fujita, Hypertension 2004 44 897 902 10.1161/01.HYP.0000146536.68208.84 15477382